Stocks and Investing
Stocks and Investing
Fri, June 16, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, June 15, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Yatin Suneja Reiterated (XENE) at Strong Buy and Held Target at $49 on, Jun 15th, 2023
Yatin Suneja of Guggenheim, Reiterated "Xenon Pharmaceuticals Inc." (XENE) at Strong Buy and Held Target at $49 on, Jun 15th, 2023.
Yatin has made no other calls on XENE in the last 4 months.
There are 5 other peers that have a rating on XENE. Out of the 5 peers that are also analyzing XENE, 0 agree with Yatin's Rating of Hold.
These are the ratings of the 5 analyists that currently disagree with Yatin
- Laura Chico of "Wedbush" Maintained at Buy with Increased Target to $47 on, Wednesday, May 10th, 2023
- Charles Duncan of "Cantor Fitzgerald" Initiated at Buy and Held Target at $58 on, Tuesday, April 25th, 2023
- Tessa Romero of "JP Morgan" Maintained at Buy with Increased Target to $55 on, Tuesday, April 25th, 2023
- Serge Belanger of "Needham" Reiterated at Strong Buy and Held Target at $50 on, Friday, April 21st, 2023
- Brian Abrahams of "RBC Capital" Reiterated at Buy and Held Target at $51 on, Wednesday, March 22nd, 2023
Contributing Sources